Jakarta, Dec. 16 -- Indonesia's Food and Drug Supervisory Agency (BPOM) says the provision of radioisotope and radiopharmaceutical production facilities is a crucial step in ensuring the availability of vital products for cancer treatment.

"This facility is an important step in the national health transformation, particularly in guaranteeing the availability of safe, high-quality, and internationally standardized vital products for cancer treatment," BPOM Head Taruna Ikrar said in Jakarta on Tuesday.

He made the remarks at the inauguration of a radioisotope and radiopharmaceutical production facility operated by PT Global Onkolab Farma, a subsidiary of Kalbe Group, in Sidoarjo, East Java.

Radiopharmaceutical facilities are specialized ...